ASX - By Stock
|
BOT |
Re:
Ann: Application for quotation of securities - BOT
|
|
Micko22
|
11 |
3.8K |
3 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
11
|
3.8K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Successful Completion of Human Factors Study
|
|
Micko22
|
52 |
15K |
14 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
52
|
15K
|
14
|
|
ASX - By Stock
|
OSL |
Re:
AGM 2023 & Resolutions
|
|
Micko22
|
17 |
7.1K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
17
|
7.1K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
13K |
4.7M |
9 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
13K
|
4.7M
|
9
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Micko22
|
67 |
23K |
0 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
67
|
23K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Micko22
|
67 |
23K |
1 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
67
|
23K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Micko22
|
67 |
23K |
1 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
67
|
23K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Micko22
|
13 |
2.9K |
0 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
13
|
2.9K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Micko22
|
13 |
2.9K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
13
|
2.9K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Micko22
|
13 |
2.9K |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
13
|
2.9K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
13K |
4.7M |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
13K
|
4.7M
|
4
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Medical AGM on 29th of November 2023
|
|
Micko22
|
3 |
1.3K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil gaining traction in the Israeli healthcare market
|
|
Micko22
|
6 |
2.5K |
2 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
6
|
2.5K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil gaining traction in the Israeli healthcare market
|
|
Micko22
|
6 |
2.5K |
2 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
6
|
2.5K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil gaining traction in the Israeli healthcare market
|
|
Micko22
|
6 |
2.5K |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
6
|
2.5K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
5 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
3 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
GSR |
Re:
Ann: Release of Shares from Voluntary Escrow
|
|
Micko22
|
15 |
3.0K |
4 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
15
|
3.0K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
4 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Micko22
|
65 |
17K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
65
|
17K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
13K |
4.7M |
9 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
13K
|
4.7M
|
9
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
5 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Micko22
|
65 |
17K |
0 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
65
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
AGM 2023 & Resolutions
|
|
Micko22
|
17 |
7.1K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17
|
7.1K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
AGM 2023 & Resolutions
|
|
Micko22
|
17 |
7.1K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17
|
7.1K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
AGM 2023 & Resolutions
|
|
Micko22
|
17 |
7.1K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17
|
7.1K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Micko22
|
65 |
17K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
65
|
17K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: September 2023 Quarterly Activities Report and Appendix 4C
|
|
Micko22
|
46 |
9.9K |
9 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
46
|
9.9K
|
9
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Micko22
|
65 |
17K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
65
|
17K
|
1
|
|
ASX - By Stock
|
GSR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Micko22
|
99 |
21K |
12 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
99
|
21K
|
12
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Micko22
|
65 |
17K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
65
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
0 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
13K |
4.7M |
8 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
13K
|
4.7M
|
8
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
0 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
0 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
2 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
62
|
17K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
5 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
GSR |
Re:
Ann: High-Grade Intercepts Extends Potential at Burbanks
|
|
Micko22
|
85 |
22K |
5 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
85
|
22K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
Micko22
|
62 |
17K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
13K |
4.7M |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
13K
|
4.7M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
7 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
2 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves SOFDRA as Trade Name for Sofpironium Bromide
|
|
Micko22
|
74 |
17K |
7 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
74
|
17K
|
7
|
|